However, there is a problem facing the treatment of osteoporosis, and it is the lack of research into new therapies, leading to a limited pipeline of new treatments coming through. In the UK ...
the efficacy data do not clearly show that PTH should be selected over antiresorptive therapies for the treatment of osteoporosis. In addition, PTH is expensive and must be administered daily via ...
Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov ... serve as diagnostic tools and potential targets for treatments. Drawing from a large database of ...